PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsRNA Interference wins Nobel Prize

BioNews

RNA Interference wins Nobel Prize

Published 9 June 2009 posted in News and appears in BioNews 379

Author

Dr Laura Bell

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Two US scientists have been awarded the Nobel Prize for Medicine for discovering a fundamental mechanism which regulates the expression of genes, called RNA interference (RNAi). Andrew Fire of the Stanford School of Medicine and Craig Mello of the University of Massachusetts Medical School won a shared...

Two US scientists have been awarded the Nobel Prize for Medicine for discovering a fundamental mechanism which regulates the expression of genes, called RNAi (RNA interference). Andrew Fire of the Stanford School of Medicine and Craig Mello of the University of Massachusetts Medical School won a shared £724,337 for their discovery which was published in the journal Nature in 1998.


RNAi, which occurs normally in plants and animals, allows a gene to be specifically 'silenced'. Our genome operates by sending instructions from DNA in the form of mRNA (messenger RNA) for the manufacture of proteins. When RNAi occurs, tiny sections of RNA in complex with other proteins, bind to a gene's mRNA and destroy it before a protein can be produced.


RNAi plays a key role in mobilising the body's natural defence against viruses, and in controlling genes. Scientists can manipulate this process by introducing tailor-made RNAi sequences to deliberately target and block the activity of a specific gene. This helps them determine the gene function and it has the potential to help researchers shut down genes which cause harm to the body. Besides fighting viral infection, it is hoped that the method may be used to combat cancer, endocrine disorders and cardiovascular disease in the future.


The award is among the quickest to be bestowed, just eight years after the research was first published. Nick Hastie, director of the Human Genetics Unit at the Medical Research Council, UK told Nature 'Their findings have led to an enormous scientific revolution, they have opened up a whole new area of biology with great medical application'. The method is now widely used as a genetic tool and is a promising candidate for future therapies.


The Nobel Prize for Chemistry was awarded to Roger Kronberg of Stanford University for his work unravelling the molecular details of transcription (the process of transferring genetic information from DNA to mRNA) in 2001. Kornberg deciphered the structure of RNA polII, an enzyme which helps transfer information form DNA to mRNA. If this process goes wrong it can cause a whole host of diseases from cancer to diabetes. Understanding this process in more depth is vital to developing new treatments for disease.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
8 November 2013 • 3 minutes read

Accurate editing of human DNA now possible, say scientists

by Dr Anna Cauldwell

A molecular technique that enables any part of the human genome to be altered with extreme precision has been hailed by scientists as a breakthrough in genetics...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
8 October 2012 • 2 minutes read

Professors Gurdon and Yamanaka awarded Nobel Prize for work on stem cells

by Dr Antony Starza-Allen

Professor Sir John Gurdon of the University of Cambridge has been jointly awarded the Nobel Prize for his work on stem cells. He shares the prize for medicine or physiology with Professor Shinya Yamanaka from Japan...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

RNA therapy trial success

by Dr Jess Buxton

The first clinical trial based on a promising new technology called RNA interference (RNAi) has shown that it could soon be used to treat an eye disorder. The trial was designed to test the safety of the technique for treating a disease called wet age-related macular...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

More new research presented at US gene therapy meeting

by Heidi Nicholl

Research ranging from tackling muscle regeneration for injured athletes to a potential cure for haemophilia has been presented at the American Society of Gene Therapy meeting at Baltimore, Maryland. A team from the University of Pittsburgh has successfully used gene therapy techniques to promote accelerated skeletal muscle...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Sperm donor 'crisis' in UK

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

4 July 2022 • 2 minutes read

Genetic variant increases Alzheimer's risk, especially in women

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856